RadioGel™
Radiogel™ is a hydrogel liquid containing tiny yttrium-90 phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.
Learn More
IsoPet®
The Isopet® Solutions division utilized university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. Testing on feline sarcoma at the Washington State University was completed in 2018 and testing on canine soft tissue sarcomas at the University of Missouri was completed in 2019.
IsoPet® Therapy is readily available at The University of Missouri and select Regional Clinics.
Learn More
them to provide valuable insight to ultimately gain final approval.
(Dr. Mike Korenko CEO • President | September 20, 2021 Press Release)
Vivos Inc. SIGNS A MOU FOR A NEW REGIONAL CLINIC IN NEW YORK FOR ISOPET® THERAPY
(Richland WA October 18, 2021) Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that it signed a Memorandum of Understanding with the Animal Hospital Surgical Center in East Meadow
New York on Long Island to become an IsoPet regional therapy center. Vivos Inc is currently working on obtaining the radioactive material handling license and on completing their
certification training. They will be specializing in treating the margin of cancerous tumors after they have been surgically removed. This is expected to provide additional life
extension. This application was recommended by our Veterinary Medicine Advisory Board.
Full Press Release
